Log in to save to my catalogue

Epigenetic regulation of TP53 is involved in prostate cancer radioresistance and DNA damage response...

Epigenetic regulation of TP53 is involved in prostate cancer radioresistance and DNA damage response...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_65286e906b2b4ab4ae73151352e131b7

Epigenetic regulation of TP53 is involved in prostate cancer radioresistance and DNA damage response signaling

About this item

Full title

Epigenetic regulation of TP53 is involved in prostate cancer radioresistance and DNA damage response signaling

Publisher

London: Nature Publishing Group UK

Journal title

Signal transduction and targeted therapy, 2023-10, Vol.8 (1), p.395-395, Article 395

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

External beam radiotherapy (RT) is a leading first-line therapy for prostate cancer (PCa), and, in recent years, significant advances have been accomplished. However, RT resistance can arise and result in long-term recurrence or disease progression in the worst-case scenario. Thus, making crucial the discovery of new targets for PCa radiosensitizat...

Alternative Titles

Full title

Epigenetic regulation of TP53 is involved in prostate cancer radioresistance and DNA damage response signaling

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_65286e906b2b4ab4ae73151352e131b7

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_65286e906b2b4ab4ae73151352e131b7

Other Identifiers

ISSN

2059-3635,2095-9907

E-ISSN

2059-3635

DOI

10.1038/s41392-023-01639-6

How to access this item